Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $98,750 | 5 | 84.6% |
| Unspecified | $11,940 | 10 | 10.2% |
| Food and Beverage | $4,583 | 149 | 3.9% |
| Travel and Lodging | $1,196 | 4 | 1.0% |
| Education | $321.00 | 6 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $112,587 | 25 | $0 (2024) |
| ABBVIE INC. | $699.76 | 21 | $0 (2024) |
| Lilly USA, LLC | $604.11 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $545.84 | 17 | $0 (2024) |
| GENZYME CORPORATION | $432.88 | 13 | $0 (2024) |
| Dermavant Sciences, Inc. | $430.39 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $244.79 | 13 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $190.38 | 7 | $0 (2024) |
| UCB, Inc. | $153.76 | 7 | $0 (2024) |
| Amgen Inc. | $143.24 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,956 | 40 | PFIZER INC. ($9,106) |
| 2023 | $1,535 | 39 | PFIZER INC. ($399.20) |
| 2022 | $22,780 | 26 | PFIZER INC. ($22,222) |
| 2021 | $79,617 | 24 | PFIZER INC. ($79,080) |
| 2020 | $266.45 | 11 | Janssen Biotech, Inc. ($72.00) |
| 2019 | $2,155 | 17 | PFIZER INC. ($1,780) |
| 2018 | $131.88 | 7 | Novartis Pharmaceuticals Corporation ($57.72) |
| 2017 | $349.78 | 10 | GENZYME CORPORATION ($116.08) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $121.54 | General |
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $68.99 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Immunology | ||||||
| 09/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Immunology | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 07/02/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 07/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 06/28/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2024 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 06/13/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Immunology | ||||||
| 05/22/2024 | PFIZER INC. | — | — | In-kind items and services | $1,400.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 05/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $38.71 | General |
| Category: Immunology | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: DERMATOLOGY | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Inflammation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $11,610 | 9 |
| LITFULO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $330.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,588 | 2,840 | $457,596 | $230,281 |
| 2022 | 23 | 1,623 | 3,176 | $480,123 | $249,638 |
| 2021 | 24 | 1,771 | 4,052 | $534,625 | $280,438 |
| 2020 | 24 | 1,667 | 4,133 | $474,325 | $208,830 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 625 | $112,500 | $63,331 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 852 | $102,300 | $63,238 | 61.8% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 112 | 180 | $37,800 | $17,587 | 46.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 132 | 191 | $34,380 | $14,699 | 42.8% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 98 | 136 | $27,160 | $13,034 | 48.0% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 51 | 78 | $17,940 | $9,389 | 52.3% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 65 | 92 | $17,480 | $7,413 | 42.4% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 44 | 62 | $13,630 | $5,596 | 41.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 25 | 33 | $16,170 | $5,407 | 33.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $7,420 | $4,352 | 58.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $6,720 | $4,279 | 63.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 30 | $12,300 | $3,871 | 31.5% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 12 | 15 | $8,250 | $3,199 | 38.8% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 13 | 20 | $8,850 | $2,827 | 31.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 15 | $6,450 | $2,275 | 35.3% |
| 11303 | Shaving of skin growth of body, arms, or legs, more than 2.0 cm | Office | 2023 | 15 | 19 | $5,410 | $2,067 | 38.2% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 24 | 28 | $4,860 | $1,805 | 37.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 139 | $5,560 | $1,666 | 30.0% |
| 11305 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 14 | 25 | $4,000 | $1,637 | 40.9% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 13 | $2,626 | $1,453 | 55.3% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 17 | $2,550 | $862.93 | 33.8% |
| 87101 | Fungal culture (mold or yeast) of skin, hair, or nail | Office | 2023 | 19 | 22 | $1,650 | $166.32 | 10.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 20 | $120.00 | $113.19 | 94.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 38 | 143 | $1,470 | $13.28 | 0.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 382 | 627 | $112,860 | $66,286 | 58.7% |
About Dr. Ronald Shore, M.D
Dr. Ronald Shore, M.D is a Dermatology healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144258757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Shore, M.D has received a total of $116,790 in payments from pharmaceutical and medical device companies, with $9,956 received in 2024. These payments were reported across 174 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($98,750).
As a Medicare-enrolled provider, Shore has provided services to 6,649 Medicare beneficiaries, totaling 14,201 services with total Medicare billing of $969,187. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Rockville, MD
- Active Since 06/30/2006
- Last Updated 10/19/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1144258757
Products in Payments
- SKYRIZI (Biological) $699.76
- TREMFYA (Drug) $439.68
- VTAMA (Drug) $430.39
- TALTZ (Drug) $418.43
- DUPIXENT (Biological) $238.83
- COSENTYX (Biological) $228.35
- Tremfya (Drug) $159.00
- Otezla (Drug) $143.23
- ATOPIC DERMATITIS - DISEASE (Drug) $116.08
- OPZELURA (Drug) $114.15
- ACZONE (Drug) $106.06
- Cimzia (Drug) $89.69
- DUPIXENT (Drug) $86.30
- DUOBRII (Drug) $85.98
- REMICADE (Biological) $72.16
- LITFULO (Drug) $68.62
- Bimzelx (Biological) $64.07
- ENSTILAR (Drug) $56.34
- OLUMIANT (Drug) $47.83
- BRYHALI (Drug) $36.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Rockville
Dr. Todd Colonna, Md, MD
Dermatology — Payments: $27,249
Dr. Jay Barnett, M.d, M.D
Dermatology — Payments: $14,233
Sara Brooks
Dermatology — Payments: $6,586
Ms. Deepa Patel, M.d, M.D
Dermatology — Payments: $6,374
Dr. Timothy Curtin, M.d, M.D
Dermatology — Payments: $5,923
Caroline Yeager, M.d, M.D
Dermatology — Payments: $4,611